Laurie Toich, Assistant Editor

Top news of the day from across the health care landscape.

The CVS-Aetna acquisition could have several implications for pharmacies and patients.

Genetically engineering the gut microbiome may hold the key to treating Crohn’s disease.

Patients receiving adjuvant chemotherapy are at a high risk of new persistent opioid use.

A newly-discovered eczema subtype may be linked to asthma and allergies.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Centers for Medicare & Medicaid Services proposed national coverage determination of the FoundationOne CDx test.

The FDA extended the approval of evolocumab (Repatha, Amgen) to include the prophylaxis of heart attacks, strokes, and coronary revascularizations in adults with established heart disease.

Evolocumab (Repatha) is the only PCSK9 inhibitor approved to prevent heart attack, stroke, and coronary revascularization.

FDA plans to further expedite novel treatments under the 21st Century Cures Act.

A second HIV test may avoid significant costs.

Development of tirasemtiv halted due to poor performance in a late-stage clinical trial.

Nearly 700 million individuals around the world will develop diabetes by 2045, many of whom are undiagnosed.

Women with type 2 diabetes were 43% more likely to develop estrogen receptor negative breast cancer than patients without diabetes.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Trastuzumab-dkst (Ogivri) is the second biosimilar approved for cancer.

Patients with a partner were nearly twice as likely to finish 6 months of chemotherapy for colon cancer.

Nearly 21 million individuals with HIV had access to antiretroviral therapy (ART) in June 2017 compared to 685,000 HIV-positive patients in 2000.

Twenty-five states can participate in value-based insurance designs for Medicare Advantage plans in 2019.

Rising cancer drug costs have become inreasingly worrisome for patients and health care providers. Despite the entry of competitors in the market, treatment costs continue to climb over time, according to a study recently published by the Journal of Clinical Oncology.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

A report suggests Amazon may be selling improperly marketed supplements and medical devices.

Millions of individuals gain access to HIV treatment, but there are significant gaps that need to be addressed to end the epidemic.

Patients with severe psoriasis were 64% more likely to develop diabetes than control patients.

A new system allows researchers to test multiple drug combinations in cultured cancer stem cells from patients.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.